Advinus optimistic about diabetes drug candidate

05/4/2009 | Business Standard (India)

Advinus Therapeutics plans to begin in June clinical trials of an experimental molecule that could be categorized under a new class of diabetes drugs, CEO Rashmi Barbhaiya said. The compound is being developed in Advinus' facility in Pune, India, which handles seven to eight drug-discovery programs.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX